Sign in
Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia
Journal article   Open access  Peer reviewed

Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia

Salem Bahashwan, Cecile Molucon-Chabrot, Eric Hermet, Aurelie Ravinet, Aurore Douge, Lauren Veronese, Andrei Tchirkov, Richard Lemal, Marc G. Berger, Richard Veyrat-Masson, …
American journal of hematology, Vol.94(1), pp.E32-E35
01/01/2019
PMID: 30370957

Abstract

Hematology Life Sciences & Biomedicine Science & Technology
url
https://doi.org/10.1002/ajh.25332View
Published (Version of record) Open

Metrics

1 Record Views

Details